Numbers 7 Flashcards
Risk OASI after vacuum
4%
Risk OASI after forceps
8%
After previous OASI, how many opted for ELCS
25%
PPH recurrence
25%
Prophylactic uterotonics reduce bleeding by…
60%
Warm compress reduces OASI by..
RR 0.48
% women with worsening faecal symptoms after 2nd VD and previous OASI
17%
Decrease in indirect maternal mortality rates between 2010-2012 by
23%
% women who conceive post TOA lap and drainage
32-63%
% women who conceive post TOA with just antibiotics
4-15%
% women in urinary retention due to Fowler’s
20%
Cx rate of laparoscopic myomectomy
11%
2% serious
Classical PKU - level of phenylalanine
> 1200
Incidence PKU
1:10,000
% women who develop fibroid complications during pregnancy
10-30%
Risk of placenta praevia with fibroids
doubles
% subfertility in fibroids
5-10%
% women who developed placenta accreta post UAE
11%
NNT with MgSO4 to prevent 1 cerebral palsy <30/40
46
NNT with MgSO4 to prevent 1 cerebral palsy 32-34/40
56
Incidence of nerve entrapment after Pfannenstiel
3.7%
CPP - if negative TVS, likelihood of pathology at diagnostic laparoscopy
20%
Risk PTB with pulmonary hypertension
> 85%
% deep infiltrating endometriosis recurrence post surgery
5-25%
% women who avoided further treatment after TCRF for fibroids
70-80%
% women with PMS
24-40%
% women with severe PMS
5-8%
% women with PMS who improve with placebo
36-43%
Baseline risk of breast cancer in menopausal women over 7.5yrs
22-48:1000
Risk of leiomyosarcoma after surgery for presumed fibroid
1:340
% pregnancy rate reduction by submucosal fibroids
70%
GnRH agonists shrink fibroids by..
35-65%
Mifepristone shrinks fibroids by…
50% over 6/12
UAE reduces fibroid volume by
40-70%
UAE risk of hsyterectomy
2.9%
UAE risk of POI
1-2%
Number of women who need further intervention after UAE
25% <40yo
10% >40yo
% women with worsening sexual function post UAE
10%
26% improve
Vaginal vault prolapse prevalence
8-12%
Perinatal mortality
7.7:1000
Neonatal mortality
3.2:1000
% suicide by violent means
82%
% suicide by hanging
> 50%
% pulmonary HTN in SLE
4.2%
% AFLP developing renal impairment
14%
3% requiring renal replacement
Risk of maternal haemorrhage at full dilated CS
4.7-10%
vs 2.9% at instrumental
Risk of neonatal trauma at full dilated CS
9%
vs 22% at instrumental
Risk SCBU admission at full dilated CS
11%
vs 6% instrumental
% bladder pain syndrome improved with stress management
80%
% bladder pain syndrome improved with regular exercise
65%
Risk of bleeding in operative vaginal delivery
1-4:10
Risk cephalohaematoma in ventouse
1-12:100
Risk of lacerations in operative vaginal delivery
1:10
Risk of neonatal jaundice/ hyperbilirubinaemia
5-15:100
Risk of retinal haemorrhage in operative vaginal delivery
17-38:100
Risk of extensive tear in vacuum
1:10
Risk of extensive tear in forceps
1:5
Risk of subgaleal haematoma in vacuum
3-6:1000
Risk of ICH in operative vaginal delivery
5-15:10,000
Risks in CS at 9-10cm
33:100
Risks in CS at 0-1cm
17:100
Risks in EMCS
24:100
Risks in ELCS
16:100
Risk of bleeding in first stage CS
2.9%
Risk of bleeding in 2nd stage CS
10%
Risk of infection in CS
6:100
Risk of post op ileus in CS
12%
Risk of readmission in CS
5:100
Risk of repeat EMCS in future in CS
1:4
Risk of marks/lacerations on babe in CS
1-2:100
Risk of hysterectomy in CS
1:1000
Risk of further surgery/return to theatre in CS
5:1000
ITU admissions in CS
9:1000
VTE risk in CS
4-16:10,000
Bladder injury in CS
1:1000
Ureteric injury in CS
3:10,000
Risk of death in CS
1:12,000
Risk of requiring blood transfusion in abdominal hysterectomy
23:1000
Risk of abscess/infection in abdominal hysterectomy
2:1000
Risk of serious risks in abdominal hysterectomy
4:100
Risk of further surgery/return in abdominal hysterectomy
7:1000
Risk of bowel damage in abdominal hysterectomy
4:10,000
Risk of death in abdominal hysterectomy
32:100,000
% PHVP for prolapse
11%
% PHVP for benign gynae
1.8%
Maximum female flow rate
15ml/s
Fetal loss with untreated APS
90%
Risk of stillbirth at 43/40
5:1000
